⏳ Fetching live dividend data...
Home › Calculator › GNBTQ Dividend Calculator 2026
Generex Biotechnology Corporation · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in GNBTQ → $1.02400512001152e+61M in 10 years · $853,337,173,341,013,400,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
Generex Biotechnology Corporation, founded in 1983 and headquartered in Miramar, Florida, was involved in diverse areas within the biotechnology and medical device industries. Initially, the company concentrated on developing and administering large molecule pharmaceutical formulations to the oral cavity using a specialized hand-held aerosol applicator across Canada and the United States. A prominent product from this initiative was Generex Oral-lyn, an oral insulin. Generex also had a research and development pipeline that included AE37, a synthetic peptide vaccine. This vaccine, which had completed Phase IIb clinical trials, aimed to elicit a robust and specific immune response against HER-2/neu oncogene-expressing tumors in patients battling breast and prostate cancer. Furthermore, the corporation played a role in the diagnostics sector. It developed, manufactured, and distributed rapid, point-of-care in-vitro medical diagnostic tests for a range of infectious diseases, such as human immunodeficiency virus (HIV), tuberculosis, malaria, hepatitis B, hepatitis C, and syphilis, among others, alongside offering corresponding test kits and cassettes. The company's offerings extended to other therapeutic and medical products, including Excellagen, a wound-conforming gel, as well as developing immunotherapeutic products, additional vaccines, and an extracellular matrix hydrogel solution intended as a tissue-engineered therapy for Ulcerative Colitis. In the surgical and orthopedic realm, Generex produced and marketed foot and ankle surgical kits, comprising plates, screws, and instruments. It also functioned as a distributor for a wide array of surgical supplies, orthopedic implants, artificial joints, biologics, various medical devices, and regenerative medicine products. Additionally, the company served as the general partner for a Management Services Organization. However, a significant event occurred on April 23, 2022, when an involuntary petition for liquidation under Chapter 7 was filed against Generex Biotechnology Corporation in the U.S. Bankruptcy Court for the Southern District of Florida. This petition subsequently received court approval on June 6, 2022.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GNBTQ position with:
Real after-tax yield depends on where you live and how you hold GNBTQ.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 200000000.00% | 199999997.20% | $20,000,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 170000000.00% | 169999997.20% | $17,000,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 160000000.00% | 159999997.20% | $16,000,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 200000000.00% | 199999997.20% | $20,000,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 182500000.00% | 182499997.20% | $18,250,000,000 / yr |
| 🇨🇦 TFSA | 0% | 200000000.00% | 199999997.20% | $20,000,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 150000000.00% | 149999997.20% | $15,000,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 170000000.00% | 169999997.20% | $17,000,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 140000000.00% | 139999997.20% | $14,000,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 147250000.00% | 147249997.20% | $14,725,000,000 / yr |
| 🇫🇷 FR Taxable | 30% | 140000000.00% | 139999997.20% | $14,000,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
GNBTQ pays quarterly — 4 times per year. Next ex-div: TBD.
How GNBTQ compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GNBTQ sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GNBTQ dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Generex Biotechnology Corporation (GNBTQ) is currently trading at $0.00, trading near its 52-week low. The current dividend yield is 200000000.00% based on an annual payout of $2.00 per share.
Generex Biotechnology Corporation (GNBTQ) is a healthcare stock currently trading at $0.00 with a dividend yield of 200000000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →